Search

Search Constraints

You searched for: Author/Creator Roh, Jaroslav

Search Results

1. 79 Effective cardioprotection against anthracycline cardiotoxicity in isolated cardiomyocytes and rabbits is based on dexrazoxane interaction with topoisomerase II beta instead of iron chelation by its metabolite ADR-925. (May 2019)

2. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products. (28th March 2016)

7. Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation. (November 2021)

8. Development of water-soluble 3, 5-dinitrophenyl tetrazole and oxadiazole antitubercular agents. Issue 20 (15th October 2017)

9. Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite. (1st December 2017)